Anette Müllertz

Title: Anette Müllertz: Innovator in Fatty Acid Drug Delivery Systems

Introduction:

Anette Müllertz, based in Charlottenlund, Denmark, has made significant contributions to the field of pharmaceutical sciences through her innovative work in drug delivery systems. With a total of two patents to her name, her research focuses on the use of fatty acid oil mixtures in enhancing drug bioavailability.

Latest Patents:

Anette Müllertz's latest patents include groundbreaking compositions that comprise a fatty acid oil mixture and a free fatty acid. These patents detail the methods and applications of these compositions, particularly in formulating self-nanoemulsifying drug delivery systems (SNEDDS), self-microemulsifying drug delivery systems (SMEDDS), and self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. The preconcentrates are specifically designed from preferred fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), available in various forms like ethyl ester and triglyceride. Additionally, her patents unveil coated capsules and tablets featuring a fatty acid oil mixture, which are optimized for oral administration and designed for efficient drug delivery.

Career Highlights:

Anette Müllertz is affiliated with Pronova Biopharma Norge AS, where her expertise in drug formulation and delivery systems positions her as a key player in the biopharmaceutical industry. Her work not only contributes to advancing drug delivery technologies but also enhances patient outcomes through improved medication efficacy.

Collaborations:

Throughout her career, Anette has collaborated with prominent colleagues such as Gunnar Berge and Svein Olaf Hustvedt. These partnerships have facilitated the exchange of ideas and innovation, fostering a collaborative environment that enhances the impact of their research on the industry.

Conclusion:

Anette Müllertz's contributions to the field of drug delivery systems exemplify the role of innovation in improving pharmaceutical formulations. Through her patents and collaborative efforts, she continues to pave the way for advancements that may significantly benefit patient care and treatment efficacy.